Curaleaf’s Liquid Medical Marijuana Inhaler Becomes First of Its Kind Registered in Australia
- Curaleaf International's Que Medical Inhalation Device (QMID) became the first liquid medical marijuana inhalation device to receive regulatory approval in Australia, being added to the Australian Register of Therapeutic Goods (ARTG) as a Class IIb medical device.
- The TGA listing identifies Vicki Partridge Pty Ltd as the Australian sponsor and Jupiter Research LLC as the manufacturer, with QMID designed specifically for delivering Cannabis sativa extracts through inhalation using compatible cartridges and standardized dosing.
- QMID is distinct from other approved medical marijuana vaporizers in Australia by being the first device tailored for liquid marijuana extracts, having also previously secured Class IIa certification under EU regulations and availability in seven countries.
- Curaleaf announced that QMID was added to New Zealand’s medical-device database, allowing supply there, and highlighted that ARTG registration is generally required for medical marijuana vaping devices in Australia before import, manufacture, or supply.
Curaleaf International says its liquid medical marijuana inhalation device has become the first of its kind to receive regulatory approval in Australia, following its inclusion in the country’s national register of therapeutic products.
Australia’s Therapeutic Goods Administration (TGA) added the Que Medical Inhalation Device (QMID) to the Australian Register of Therapeutic Goods on September 15. The device is registered as a Class IIb medical device under ARTG number 531287.
The TGA listing identifies Vicki Partridge Pty Ltd as the Australian sponsor and Jupiter Research LLC as the manufacturer.
Curaleaf, which developed the device in partnership with Jupiter Research, announced the registration Friday. The company says QMID is the first device specifically intended to deliver Cannabis sativa extracts through inhalation to receive regulatory approval in Australia.
The distinction is narrower than being Australia’s first approved medical marijuana vaporizer. The TGA already lists several devices intended for vaporized medical marijuana, including the SyqeAir Inhaler, Mighty+ Medic, Volcano Medic 2 and Grenco Medical Elite II. QMID is the first registered device designed specifically for liquid marijuana extracts, according to Curaleaf.
The reusable handheld device is designed to work only with compatible cartridges and automatically aerosolizes the liquid medicine when a patient inhales. Curaleaf says the system is designed to provide standardized and consistent dosing.
QMID previously became the first handheld liquid medical marijuana inhalation device certified as a Class IIa medical device under European Union medical-device regulations in May 2025.
The company says the device is now available in seven countries.
Curaleaf also announced that QMID was added to New Zealand’s Web Assisted Notification of Devices database on September 17, allowing it to be supplied there under the country’s medical-device framework.
Australia generally requires medical marijuana vaping devices to be included in the ARTG before they can be imported, manufactured or supplied, although pathways exist for unregistered devices when registered products are not considered clinically appropriate.